Insphero, Inc.
Portland, ME Part of Insphero AG
- UEI
- FCCCVSMNHGJ6
- CAGE
- 7WFG6
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
SJC4FD6PQH65
-
Parent
SJC4FD6PQH65
- SAM.gov registration date
- Physical address
- 770 Congress St, Portland, ME 04102, USA
- Website
- insphero.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $46,830 |
| FY2024 | $209,744 |
| FY2023 | $109,577 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Battelle Memorial Institute | HHSN273201400027C | $111,409 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Xylyx Bio, Inc. | NY | — |
| Lena Biosciences, Inc. | Atlanta, GA | — |
| Fujifilm Cellular Dynamics, Inc. | — | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Mattek Corporation | Ashland, MA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Endomimetics, Inc. | Birmingham, AL | — |
About the company
Insphero Inc. is a foreign-owned, for-profit corporate entity registered in SAM.gov that specializes in advanced 3D cell culture technologies and in vitro biological models. Headquartered in Brunswick, Maine, the company is a subsidiary of Insphero AG and focuses on developing sophisticated cellular platforms for scientific research, particularly in drug testing and toxicity assessment. The company is primarily oriented toward providing specialized biological products to federal agencies, with a particular emphasis on creating complex, three-dimensional cellular models that can simulate human tissue environments for research purposes.
The federal contract awards demonstrate Insphero's expertise in producing highly specialized 3D liver microtissues and cellular models for scientific research, predominantly for agencies within the Department of Health and Human Services. Specifically, the company has been awarded multiple prime contracts from the National Institute on Drug Abuse (NIDA) and the National Center for Advancing Translational Sciences (NCATS), with contract values ranging from $22,800 to $96,829.63. These contracts involve providing intricate 3D liver spheroids composed of human primary hepatocytes, liver endothelial cells, and Kupffer cells, which are used for critical research applications such as drug-induced liver injury assays, toxicity testing, viral infectivity studies, and safety assessments for emerging pharmaceutical compounds. Additionally, Insphero has received several subcontract awards from Battelle Memorial Institute, supporting the National Toxicology Program (NTP) and RETOX programs, further highlighting their specialized capabilities in creating advanced cellular research models.
Quick answers
Is Insphero, Inc. registered in SAM.gov?
Yes. Insphero, Inc.'s SAM.gov registration is active through January 28, 2027.
How much has Insphero, Inc. received in federal contracts?
Federal contracts obligated $46,830 to Insphero, Inc. in fiscal year 2025 and $366,150 in fiscal years 2023 through 2027.
How does Insphero, Inc. rank among federal contractors?
Insphero, Inc. ranked #73 in NAICS 325414 in FY2025.
What is Insphero, Inc.'s most recent federal award?
Insphero, Inc.'s most recent federal contract award is Insphero, INC.:1302435 [25-000250] (75N95025P00047), from National Institute on Drug Abuse (NIH), on December 5, 2024.
On GovTribe
See Insphero, Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors